CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in NPCE — NeuroPace Inc

CIK 884546 SAN FRANCISCO, CA

Position in NPCE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,236,734

+$318,720 QoQ

Shares Held

77,831

+11.5% QoQ

Ownership

0.227%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 112 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $9,313,109,521 across 79 Medical Devices names. NPCE ranks #63 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	59,674,507	$5,414,864,764
2	MDT	Medtronic plc	8,905,319	$696,663,105
3	SYK	Stryker Corp	2,148,933	$676,570,065
4	BSX	Boston Scientific Corp	9,223,151	$393,644,084
5	EW	Edwards Lifesciences Corp	3,693,034	$334,071,855
6	DXCM	Dexcom Inc	3,439,164	$231,627,694
7	GEHC	GE HealthCare Technologies Inc.	3,129,530	$200,321,215
8	STE	STERIS plc	666,633	$140,372,910

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,236,734	77,831	+11.5%	Shares	Sole	2026-08-14
2026-03-31	$918,014	69,811	-8.3%	Shares	Sole	2026-05-15
2025-12-31	$1,175,802	76,153	+10.6%	Shares	Sole	2026-02-13
2025-09-30	$709,833	68,849	0.0%	Shares	Sole	2025-11-10
2025-06-30	$766,977	68,849	+75.5%	Shares	Sole	2025-08-12
2025-03-31	$482,222	39,237	+7.4%	Shares	Sole	2025-09-15
2024-12-31	$408,849	36,537	0.0%	Shares	Sole	2025-02-06
2024-09-30	$254,662	36,537	0.0%	Shares	Sole	2024-11-12
2024-06-30	$276,219	36,537	+115.3%	Shares	Sole	2024-08-12
2022-03-31	$139,307	16,968	-2.8%	Shares	Sole	2022-05-13
2021-12-31	$175,875	17,448	0.0%	Shares	Sole	2022-02-11
2021-09-30	$276,550	17,448	0.0%	Shares	Sole	2021-11-16
2021-06-30	$415,087	17,448	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.